Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Novo Nordisk A/S US: News Health & Science
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags LILLY DRN Viking Therapeutics Inc Health & Science
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Health & Science Health care industry Healthy Returns
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Breaking News: Business Business News Biotechnology
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Biotechnology Alzheimer's disease Biotech and Pharmaceuticals
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Tickers HIMS LLY NEWS NVO
Tags semaglutide Benzinga LLY
From Benzinga
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Novo Nordisk A/S Science Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags LILLY DRN Companies Health care industry
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Biotech and Pharmaceuticals LILLY DRN Social issues
From CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
Tags Business News Halliburton Co Investment Strategy
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Pharmaceuticals Novo Nordisk A/S Zealand Pharma A/S
From CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
Tags Novo Nordisk A/S Business News CNBC Investigations
From CNBC.com News
CNBC Daily Open: October’s gravity bringing stocks down
Tickers JOBS OIL
Tags Novo Nordisk A/S Daily Open China Markets
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Tencent Holdings Ltd Amazon/com Inc PRO: Playbooks
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
Tags Transportation and shipping Labor unions Strikes
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
Tags Shipping Breaking News: Economy US Economy
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
Tags Social issues US: News Eli Lilly and Co
From CNBC.com News
5 things to know before the stock market opens Wednesday
Tags 5 Things to Know Economy Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Health & Science GSK plc Astellas Pharma Inc
From CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Tags Companies Health care industry Health & Science
From CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
Tags Hovnanian Enterprises Inc Constellation Energy Corp Kinder Morgan
From CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
Tickers NEWS NVO
Tags Market News Diabetes wegovy
From Benzinga
FTC sues drug middlemen for allegedly inflating insulin prices
Tags Cigna Corp Companies Business
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Tags Biotechnology Biotech and Pharmaceuticals Pfizer Inc
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Roche Holding AG Health & Science Healthy Returns
From CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
Tags Consumer Staples Inflation Technology
From CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
Tickers JOBS
Tags Market Outlook Markets Asia Markets
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Tags Companies Business Health & Science
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Novo Nordisk A/S Eli Lilly and Co Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Eli Lilly and Co Novo Nordisk A/S Social issues
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.